Biometrics: February 2014

Frost & Sullivan to Present on Mega Trends Impacting the Auto ID and Data Capture Industry at Premiere Event

MOUNTAIN VIEW, Calif., Feb. 25, 2014 /PRNewswire/ -- Frost & Sullivan is an official media partner and will present at the inaugural connect:ID event. The conference will be held on March 17-19, 2014 at the Ronald Reagan Building in Washington, DC.

Government, commercial and consumer markets are in search of answers to the growing challenges associated with securing human identity in a privacy-sensitive manner. connect:ID aims to explore these real world scenarios in an engaging, thought-provoking and inclusive environment, bringing together all the stakeholders under one roof.

As such, Frost & Sullivan's Auto Identification and Data Capture Senior Research Analyst Ram Ravi will present "Automatic identification and data capture (AIDC) technologies gaining traction – A look into the macroeconomic impact," which will examine the various identity solutions used in industries such as healthcare, automotive and banking, as well as their growth prospects in the context of the emerging socioeconomic, environmental, and regulatory environment. Also, Ravi will identify emerging applications and their impact on AIDC technology adoption level for the future.

"With biometric technologies gaining prominence across various applications, certain macroeconomic trends and their implications are expected to positively impact the adoption levels and growth of the market," said Ravi.

Ravi's presentation will be held on the second day of the event (March 18). A two-day, free-to-attend Expo (March 18-19) that explores the fusion of multiple advanced identity technologies – including biometrics, secure credentials and digital identity systems will also be held in conjunction with the event.

For more information on Frost & Sullivan's Automatic Identification and Data Capture research, please contact Jeannette Garcia, Corporate Communications, at jeannette.garcia@frost.com with your full contact details. For more information on connect:ID 2014, please contact Mark Lockie at m.lockie@sciencemediapartners.com.

Connect with Frost & Sullivan on social media, including Twitter, Facebook, SlideShare and LinkedIn, for the latest news and updates.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation. The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Join Us: Join our community

Subscribe: Newsletter on "the next big thing"

Contact:
Jeannette Garcia
Corporate Communications – North America
P: 210.477.8427
E: jeannette.garcia@frost.com
Twitter: @Frost_Sullivan
Facebook: FrostandSullivan
Linkedin: Future of Measurement and Instrumentation

http://www.frost.com

SOURCE Frost & Sullivan

Israeli-Based Biometric Security Company, FST21, Opens U.S. Office In 7 World Trade Center

NEW YORK, Feb. 25, 2014 /PRNewswire/ -- FST21, the leading biometric security company that uses a fusion of biometric and analytic technologies, announced today the opening of the company's first New York City-based office. The location, at 7 World Trade Center, establishes FST21's presence in the financial epicenter of the city and highlights the importance of convenient security in the area, while also furthering the company's investment in the U.S. market.

FST21's new office features a fully operational installment of the company's biometric security system, including the patented SafeRise In Motion Identification® technology. The security system seamlessly incorporates both biometric and analytic technology developed by the company, allowing for facial recognition, behavior analysis, voice recognition, and more.

"As we continue to expand our business, we are excited to open our office in the heart of New York's business center," says Major-General Aharon Zeevi Farkash, Founder and CEO, FST21. "Over the past year we have furthered our technology development of biometric security to reach over a 99% positive identification rate. The location further establishes our commitment to the U.S. market, while also showcasing our innovative technology in a city plagued by daily security struggles."

The New York City office is the second location in the U.S. for FST21, which also has an office in Sayreville, NJ. The company has already implemented its SafeRise technology within various locations in the New York City area, particularly the famous Knickerbocker Building and the Taino Towers.

The company was founded by Major-General Farkash, a world expert in security and former head of the Israeli Military Intelligence Directorate. For more information on FST21 please click here.

ABOUT FST21:
FST21's SafeRise provides top security and convenience by fusion of real time information for fast and automatic visitor management. It's hassle-free and allows authorized users quick and convenient access. SafeRise's In Motion Identification™ uses a fusion of biometric and analytic technologies that include facial recognition, behavior analysis, voice recognition, LPR, RFID and more.

ABOUT 7 WORLD TRADE CENTER:
7 World Trade Center opened in 2006 as the first office tower to be rebuilt at the World Trade Center. The building contains 42 office floors above a ten-story base and was New York City's first office building to be certified by the U.S. Green Building Council's Leadership in Energy & Environmental Design (LEED) rating system - achieving the gold standard in March 2006. The building's environmental design features include state-of-the-art ultra-clear exterior glass technology, high-efficiency air filtration, energy and water conservation technologies and 15,000 square feet of open park space.

SOURCE FST21

Wake Up Your Brain With SunSprite: First Wearable, Solar-Powered Device And App To Accurately Track Light Exposure

CAMBRIDGE, Mass., Feb. 25, 2014 /PRNewswire/ -- GoodLux Technology, LLC has announced the launch of its first innovation, SunSprite, a device that tracks and records the amount of bright light exposure an individual receives each day. SunSprite is the first completely solar-powered device and app combination to accurately measure bright light, helping users attain the physical and mental benefits of light exposure.

SunSprite debuted on Indiegogo today, marking the official launch of the product and its crowdfunding campaign. The device is available on Indiegogo for an introductory price of $99 and the first 100 devices will be priced at $89. SunSprite is expected to ship in late Q2 2014. Following the Indiegogo availability, SunSprite will retail for $149. It will make its first public appearance at this year's SXSW (March 7–16, 2014, Austin, Tex.).

You've heard of wearables and apps for fitness, sleep and nutrition. And now there's one for an equally important health component: sunlight. For decades, scientific studies have substantiated the effectiveness of bright light as a supplement to a healthy lifestyle. Bright light successfully wakes up the brain – especially in the winter months – and makes individuals more alert, engaged and energetic. Additionally, receiving bright light during the day can improve sleep habits, helping to regulate the natural circadian rhythm that is frequently disrupted by modern, hectic lifestyles. Studies have also shown bright light can serve as an effective remedy for a variety of conditions including depression, anxiety, ADHD and Parkinson's disease.

"We are thrilled to launch SunSprite, a wearable device that combines cutting-edge technology with the latest medical science to deliver a simple-to-use experience that will improve health on a global scale," said Edward Likovich, CEO of GoodLux. "SunSprite is easy to integrate into anyone's lifestyle. By wearing it and getting daily bright light, you will feel more energized during the day and sleep better at night."

SunSprite is small and lightweight, and, using its advanced magnetic closure, users can clip it on a shirt, collar, cuff, jacket, pocket or bag strap. The user can check the device or the corresponding mobile app to see their daily progress towards their recommended amount of bright light. Additionally, users can analyze their light exposure patterns and receive coaching through the app. SunSprite, which is manufactured in the USA, connects to an iOS device by Bluetooth® Smart technology and is completely solar-powered with absolutely no cords or cables.

To view the product video or purchase SunSprite, please visit: http://igg.me/at/sunsprite.

For additional information on the product and company, please visit: www.sunsprite.com.

About GoodLux:
GoodLux Technology, LLC strives to combine the best of science with our natural environment to improve health on a global scale. The company was founded by a team of Harvard-trained scientists, doctors, engineers and entrepreneurs on a mission to re-imagine the intersection of technology and nature. Become your brightest self on Facebook and Twitter.

SOURCE GoodLux Technology, LLC

DDC Medical (DDC), one of the World's Largest DNA Testing Laboratories, Announces License Agreement with National Institute of Standards and Technology (NIST) To Commercialize Mouse Cell Line Authentication (M-CLA) Using STR DNA Technology

reade more...

Global Market for Wearable Computing Devices Projected To Reach $30.2 Billion in 2018; Consumer Market Expected To Surge With 52% CAGR

WELLESLEY, Massachusetts, February 25, 2014 /PRNewswire/ --

BCC Research (http://www.bccresearch.com) reveals in its new report, Wearable Computing: Technologies, Applications, and Global Markets, the global market for wearable computing devices is expected to grow to $30.2 billion by 2018, with a five-year compound annual growth rate (CAGR) of 43.4%. The consumer market, the fastest moving segment overall, is projected to grow at a tremendous 52% CAGR.

Wearable or body-borne computers enable hands-free mobile real-time data monitoring, logic calculation, and network communication. Consumer applications, including wearable cameras, activity trackers, smart clothing, smart glasses, smart watches, augmented reality and gaming devices, are expected to explode onto the market over the next few years, reaching $22.1 billion by 2018. Non-consumer markets (healthcare, defense/security, enterprise, and industrial) are expected to reach $8.1 billion by 2018.

The smart watch product category is projected to account for the largest single consumer market, generating more than $12.5 billion in global annual revenues in 2018.

"Key for the future widespread adoption of smart watches in consumer markets will be for products to leverage the single unique advantage of smart watches over smart phones," said BCC Research information technology analyst Adam Weigold. "In other words, products must target consumer applications where it is a distinct advantage for a smart device to be permanently worn to prevent it from being misplaced, lost, or stolen. Hence, applications such as remote location of personal items, home automation and mobile payment processing could be "killer apps" for the smart watch."

Wearable computing: technologies, applications and global markets provides an overview of the wearable computing devices market. The report discusses recent technological advances in materials sciences, electronics, photonics, and software that are enabling a potentially vast range of new lightweight, wearable computing products to emerge. The history and current state of the market is reviewed and the types of devices available are discussed. An analysis of the industry structure, including major companies and market shares, and major markets and market drivers is made. Likely future industry developments are discussed and the future evolution of the technology is predicted. Patent evaluation, including coverage of the current state of technology, new patent applications, and newly issued patents is also included. This report is intended for developers, manufacturers, providers, suppliers, users, customers, commentators, analysts, and investors interested in where the Wearable computing devices and accessories market is heading.

Editors and reporters, who wish to speak with the analyst, should contact Steven Cumming at steven.cumming@bccresearch.com.

About BCC Research

BCC Research publishes market research reports that make organizations worldwide more profitable with intelligence that drives smart business decisions. These reports cover today's major industrial and technology sectors, including emerging markets. For more than 40 years we've helped customers identify new market opportunities with accurate and reliable data and insight. These include, but are not limited to, market sizing, forecasting, industry overviews, and identification of significant trends and key competitors. We partner with analysts who are experts in specific areas of industry and technology. Their up-to-date knowledge gives our customers unbiased measurements and assessments of these vital markets. Because our reports offer a global focus, our customers include the top companies in industries around the world as well as universities, major business schools, start-ups, consulting firms and investment companies. BCC Research is a unit of Eli Research LLC.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49-2 Walnut Park, Wellesley, MA 02481, Telephone: (+1) 781-489-7301; Email: editor@bccresearch.com as the source and publisher. Thank you.

Contact: Steven Cumming
Additional Releases: http://www.bccresearch.com/pressroom

Tel: +1-978-870-3345
Fax: +1-781-489-7308
Email: steven.cumming@bccresearch.com

SOURCE BCC Research LLC

reade more...

8KMiles Launches EzIAM to Enable Complete IAM Solution with Convenience of a Cloud-Based Service

SAN RAMON, Calif., Feb. 25, 2014 /PRNewswire/ -- 8KMiles, a leading global secure cloud solutions company powered by FuGen Solutions, today announced the launch of EzIAMTM, combining the power of reliable user provisioning and user management solutions with the benefits of a hosted, cloud-based deployment model for the fastest way to implement Identity and Access Management (IAM).

EzIAMTM is built on mature IAM technologies currently deployed by thousands of customers worldwide. It is aimed at Small and Medium Businesses (SMBs) and large enterprises that want a more flexible consumption model of SaaS via the Amazon Web Services (AWS) cloud or a secure virtual private cloud.EzIAMTM, customers reap the benefits of a SaaS-based service with reduced CAPEX costs, IT overhead, and solution complexity while increasing business agility, scale and flexibility along with 8KMiles' patented Federation Partner On-Boarding technology (MISPTM).

Customers can pay-as-they-go with individual services, or subscribe to all EzIAMTM services, centrally managed through a single dashboard. Core capabilities of EzIAMTM include advanced authentication, federated SSO and Identity Management and Governance services. Together, these three elements provide companies with low-friction, strong authentication and fraud detection, cross-domain SSO for optimum user convenience and productivity, and user lifecycle management with delegated administration and self-service access requests, password reset and profile management.

"SMBs have traditionally been disenfranchised with IAM due to the high costs, complexity, and operational demands," said Lena Kannappan, COO of 8KMiles. "With the continued explosive growth of SaaS services and the changing landscape of the business ecosystem, SMBs need a managed service that can grow with them, take care of their needs and help them quickly and painlessly establish secure business partnerships."

"IAM is hard, so we're excited to help remove complexity and friction from traditional IAM by combining it with our patented technologies," said Tony Goulding, VP Cloud Identity Solutions Presales at 8KMiles. "It's a solid combination with real, unique value. As demands on IT grow, with little or no increase in budget, EzIAMTM gives IT professionals an opportunity to focus more resources on growth and innovation."

"As cloud adoption increases exponentially every day, IAM is in greater demand," said Anand Kumar, VP Sales at 8KMiles. "Customers are demanding more choices along with a simplified identity, access and governance experience. Older, non-flexible systems are no longer meeting the needs of today's business. The 8KMiles solution is the ideal alternative for our customers to consume IAM their way."

EzIAMTM is available immediately. 8KMiles has more than six years of experience in cloud solutions. 8KMiles' team of cloud experts and enterprise-level cloud architecture is robust and tailored in its approach, helping companies power their cloud and go-to-market strategies, while achieving greater cloud computing savings and efficiencies. Please visit www.8kmiles.com for more information.

About 8KMiles

8KMiles is a global secure cloud solutions company based in the U.S. 8KMiles provides digital technology solutions - SMAC (Social, Mobile, Analytics and Cloud) for seamless connectivity between consumers, SMBs, enterprises and government agencies secured with EzIAMTM and our patented MISPTM platform for accelerated Partner federations. For more information about 8KMiles, visit www.8kmiles.com.

SOURCE 8KMiles

Biometric Identification System from SRI International Secures Access to E-Commerce Park Data Center in Curaçao

MENLO PARK, Calif., Feb. 25, 2014 /PRNewswire/ -- SRI International Sarnoff's Iris on the Move® (IOM) N-Glance™ biometric system is now protecting access to E-Commerce Park Curaçao, the first data center of its kind built in the Pan Caribbean area. E-Commerce Park provides clients with redundant continuity and disaster recovery solutions, including colocation, data storage and private cloud services. IOM N-Glance systems secure access to the colocated servers and data housed at E-Commerce Park Data Center by confirming the identity of authorized employees as they enter the facility as well as the colocation areas.

"A high level of security is critical to our business, where we manage network operations, client support, and redundant Internet access day and night," said Rob Vermeulen, CEO of E-Commerce Park. "Our clients entrust us with business-critical data, and the N-Glance iris recognition system ensures the most accurate method of identity verification of people entering our sensitive facilities."

SRI's IOM N-Glance system is easy to use and non-intrusive. Users simply glance at the system from a comfortable distance to confirm identity and gain access. The system identifies people in less than a second and processes up to 12 people per minute. It captures iris images even if a user is wearing eyeglasses or contact lenses.

"Positive identity authentication is essential for protecting intellectual property and physical IT infrastructure," said Mark Clifton, vice president, Products and Services Division at SRI International. "SRI's N-Glance systems will provide E-Commerce Park Data Center and its clients with trusted identity management in an easy-to-use, practical way."

About E-Commerce Park
E-Commerce Park N.V. is located in Curaçao (www.e-commercepark.com) and in operation since November of 2001. As the first built-for-purpose data center in the Caribbean, ECP is one of the most trusted and stable facilities in the Pan Caribbean region. With 2N redundancies on power, cooling as well as multi-homed network access, ECP is the ideal location for enterprises seeking secure and reliable colocation services. Since August 2007, E-Commerce Park is part of Columbus International, one of the largest telecommunication providers in the Caribbean (www.columbus.co).

For more information on E-Commerce Park, please visit our website or email sales@e-commercepark.com.

About SRI International

SRI International is a nonprofit research and innovation center headquartered in Silicon Valley. Government and business clients worldwide come to SRI for pioneering solutions in biomedical sciences and health, chemistry and materials, computing, education, economic development, energy, security and defense, robotics, sensing, and more. We provide research, laboratory and advisory services, technology development and licenses, deployable systems, products, and venture opportunities. Our innovations have created new industries and marketplace value, and lasting benefits to society.

Visit SRI's website and Timeline of Innovation to learn more.

SOURCE SRI International

Concise Analysis of the International Semiconductor Fabrication Material Market

DUBLIN, Feb. 25, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/ljb78p/semiconductor

) has announced the addition of the

"Concise Analysis of the International Semiconductor Fabrication Material Market"

report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

This report analyzes the worldwide markets for Semiconductor Fabrication Material in US$ Million by the following Product Segments:

Silicon Wafers Photoresists & Adjuncts Electronic Gases CMP Material OthersThe report provides separate comprehensive analytics for the US, Japan, Europe, China, South Korea, Taiwan, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 100 companies including many key and niche players such as:

Air Products and Chemicals Inc. Air Liquide SA Alent Plc Avantor Performance Materials AZ Electronic Materials SA BASF SE Key Topics Covered:

I. Introduction, Methodology & Product Definitions

II. Executive Summary
1. Industry Overview
2. Market Trends, Drivers & Issues
3. Product Overview
4. Product Innovations/Introductions
5. Recent Industry Activity
6. Focus On Select Global Players
7. Global Market Perspective

III. Market
1. The United States
2. Japan
3. Europe
4. China
5. South Korea
6. Taiwan
7. Rest Of World

IV. Competitive Landscape

Total Companies Profiled: 100 (including Divisions/Subsidiaries - 120)

The United States (62) Japan (26) Europe (17) France (3) Germany (6) The United Kingdom (3) Rest of Europe (5) Asia-Pacific (Excluding Japan) (15) For more information visit http://www.researchandmarkets.com/research/ljb78p/semiconductor

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

RELATED LINKS
http://www.researchandmarkets.com

reade more...

Concise Analysis of the International Blood Pressure Monitoring Testing Market - Forecasts to 2019

DUBLIN, Feb. 24, 2014
/PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/j8sfj8/blood_pressure

) has announced the addition of the

"Concise Analysis of the International Blood Pressure Monitoring Testing Market - Forecasts to 2019"

report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The rise in prevalence of high/low blood pressure is attributed to a geriatric population, sedentary lifestyle, lack of physical activity and rising stress. It is estimated that people above the age of 55 years have 90% risk of developing high blood pressure. The global blood pressure monitoring testing market was valued at USD 1,713.3 million in 2012 and is expected to grow at a CAGR of 11.5% from 2013 to 2019, to reach an estimated value of USD 3,661.3 million by 2019. Social, behavioral and metabolic factors determine and contribute to hypertension. Behavioral risk factors such as physical inactivity, unhealthy diet, consumption of alcohol and tobacco, increase the risk of hypertension.

Manufacturers are coming up with new and innovative digital blood pressure monitoring devices that are easy to use and provide accurate readings instantly. The digital sphygmomanometers market is expected to grow at a faster rate compared to other types of sphygmomanometers (mercury and aneroid) as they are easy to use and provide accurate results. The trend of regular monitoring is fast catching up, with patients opting for automated self-care, thus making use of personal monitoring devices. Currently, majority of the automated blood pressure monitoring devices available are based on the oscillometric method that gives accurate results, along with ease of use.

Key Topics Covered:

1 Preface

2 Executive Summary

3 Market Overview

4 Blood Pressure Monitoring Testing Market, By Segments

5 Blood Pressure Monitoring Testing Market, By Geography

6 Blood Pressure Monitoring Testing Market, By End Users

7 Competitive Landscape

8 Recommendations

9 Company Profiles

Companies Mentioned:

A&D Medical, Inc CONTEC MEDICAL SYSTEMS CO, LTD Covidien PLC GE Healthcare Masimo Corporation Nihon Kohden Corporation Omron Healthcare, Inc Philips Healthcare Shenzhen Mindray Bio-Medical Electronics Co, Ltd Spacelabs Healthcare Suntech Medical, Inc Welch Allyn For more information visit http://www.researchandmarkets.com/research/j8sfj8/blood_pressure

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

RELATED LINKS
http://www.researchandmarkets.com

reade more...

New York City Healthcare Real Estate Conference: ARC, Danbury Hospital, Kayne Anderson Real Estate, Morgan Keegan & More: Add Your Firm to this Influential List of Speakers & Attendees

HEALTHCARE & REAL ESTATE 2014 will bring together the leading national and Tri-State healthcare real estate executives, healthcare providers and industry service providers for a full-day market intelligence and networking program. 400+ are ...jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";NEW YORK, Feb. 21, 2014 /PRNewswire-iReach/ -- New Investors, New Developers, New Strategies & New Stories: Healthcare & Real Estate 2014 will bring together 300+ attendees and 40 Speakers in 12 panel discussions. Join the most active investors, developers, capital sources, brokers, tenants, healthcare providers and technology firms for an important and in-depth healthcare & real estate update on April 8. Healthcare & Real Estate 2014 is New York's largest regional one-day conference focused exclusively on healthcare and real estate in New York, New Jersey and Connecticut.

(Photo: http://photos.prnewswire.com/prnh/20140221/MN69271)

HEALTHCARE & REAL ESTATE 2014

will feature 40 speakers, including new voices and industry experts in 12 panel discussions. Agenda coverage:
* The new and changing delivery of healthcare in 2014: What's new in healthcare delivery?
* Urgent care centers update: Are they here to stay?
* Healthcare legal analysis: What are the legal ramifications of the accountable care act?
* Is the private practice of medicine going the way of the dinosaur? Who will survive and who may become extinct?
* New innovations in healthcare: What are the most profitable medical services being provided today?
* A study of healthcare design today and the efficiencies of multiple care facilities: Exploring the Importance of efficient health care design in today's multi-specialty healthcare spaces
* Investment trends in healthcare real estate, including hospitals, medical office buildings and research facilities: Who is investing in healthcare real estate today?

> View detailed agenda: http://cre-events.com/hcre2014/agenda/

"As a real estate investor and a student of the health education program at Columbia University, I was looking forward to Healthcare & Real Estate with much anticipation. The event turned out to be more than I expected: exceptionally well-organized with the highest caliber panelists whom I had the pleasure of speaking with during the breaks following the discussions. I learned about the pros and cons of entering the field and gained an in-depth view of the marketplace." - Renata Robel-Becker, TRB Investment Group, LLC

Confirmed Speakers: Hear 40 Speakers, Including New Voices & Industry Experts

* John D. Claybrook, Partner, Waller Lansden Dortch & Davis, LLP
* Jeffrey H Cooper, Chairman & Executive Managing Director, Savills
* Morris Gross, Vice President – Facilities Management, Danbury Hospital
* Todd Jensen, Chief Investment Officer, American Realty Capital Healthcare Trust
* Steven Laufer, President, Promenade Senior Living
* John Marshall, Vice President, Duke Realty
* Scott A. Mason, D.P.A, FACHE, Executive Managing Director and Leader | Healthcare, Cushman & Wakefield
* Casey N. Moore, Principal, Prudential Mortgage Capital
* Max Newland, Director – Acquisitions, Kayne Anderson Real Estate
* Frank R. Williams, Jr., Senior Managing Director – Acquisitions, Medical Properties Trust, Inc.
* Paul Wexler, Wexler Healthcare Properties, The Corcoran Group
* Jonathan L. Winer, Executive Vice President, Seavest Inc.
* Laca Wong Hammond, Head of Healthcare Real Estate – Healthcare Investment Banking, Raymond James | Morgan Keegan
* Wilkingson Germain, Investment Officer, Ventas, Inc. (tentative)

> View detailed agenda: http://cre-events.com/hcre2014/agenda/

"The current transformation of the delivery of healthcare services from a provider oriented system to a patient centric system is revolutionizing where, how, and who is now providing healthcare services. Come learn the latest trends in healthcare real estate today: who is doing the deals, where the deals are being done, and why what is happening affects every one of us."

Paul Wexler, Wexler Healthcare Properties at The Corcoran Group

NETWORKING & NEW BUSINESS DEVELOPMENT: 135 leading CRE and healthcare executives have already made plans to attend - Add your firm's name to this influential list today. 300+ are expected to attend. Attending firms, as of February 19, 2014:
* Arbor Commercial Mortgage
* Array Architects
* Beech Street Capital
* CapRate Events
* Caracor LLC
* CBRE
* Cushman & Wakefield
* Danbury Hospital
* Dare Living Associates
* Duke Realty
* EmblemHealth, Inc.
* LifeQuest
* Lillibridge Healthcare Services
* Marcus & Millichap Real Estate Investment Services
* MedDev LLC
* Medical Properties Trust, Inc.
* NAI JAMES E. HANSON
* NPV Advisors
* Promenade Senior Living
* Prudential Mortgage Capital
* Raymond James | Morgan Keegan
* Savills
* Seavest Inc.
* Simone Development
* Simone Healthcare
* Ventas, Inc.
* Voikos Construction Management
* Voikos Construction Management
* Waller Lansden Dortch & Davis, LLP
* Westage Companies
* Westage Companies
* Wexler Healthcare Properties
* Windels Marx Lane & Mittendorf, LLP

> View official conference website: http://cre-events.com/hcre2014/

> Register for this event today: https://www.regonline.com/Register/Checkin.aspx?EventID=1482046

Event Speaker/Sponsor/Exhibitor Contact: Brian Klebash | 917-460-3572 | info@cre-events.comTelephone Registration/Questions: Ronnie Niederman | 212-873-3484

CapRate Events/CRE-Events.com is an independently-owned and operated digital media firm based in New York City. Launched in June of 2011, the firm has emerged as a new leader in commercial real estate informational and networking services.

For more information or to get involved: www.cre-events.com |info@cre-events.com | 917-460-3572

Media Contact: Brian Klebash, CAPRATE Events, LLC, 6175016075, info@cre-events.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE CAPRATE Events

reade more...

Concise Company Profiles of 36 Chinese Agrochemical Manufacturers

DUBLIN, Feb. 20, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/5vsz5z/company_profiles

) has announced the addition of the

"Company Profiles of Thirty-six Chinese Agrochemical Manufacturers"

report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

China has become the largest production base and exporter of pesticides in the world. However, it's observed that most pesticides produced in China are generic products, and the whole Chinese pesticide industry faces problems such as plight of overcapacity, irrational competition, lack of world-famous brands and low added value.

During the 12th Five-Year Plan (2012-2016) period, China will make efforts to optimize the pesticide industry's structure and improve Chinese pesticides' competitiveness in the global market. Hence, the whole pesticide industry is expected to undergo a great integration and reformation, and many companies will be restructured. On the whole, it is full of opportunities and challenges in the pesticide market of China.

The 36 companies in the report are key players in China's pesticide industry, representing the top level of the domestic pesticide production and marketing.

Key Topics Covered:

Executive summary

1 Anhui Guangxin Agrochemical

2 Anhui Huaxing Chemical Industry

3 Beijing Nutrichem Biotechnology

4 Hebei Veyong Bio-Chemical

5 Hubei Sanonda

6 Hunan Haili Chemical Industry

7 Jiahua Group

8 Jiangsu Baoling Chemical

9 Jiangsu Changlong Chemicals

10 Jiangsu Changqing Agrochemical

11 Jiangsu Fengshan Group

12 Jiangsu Good Harvest-Weien Agrochemical

13 Jiangsu Huifeng Agrochemical

14 Jiangsu Kwin Group

15 Jiangsu Lanfeng Biochemical

16 Jiangsu Sevencontinent Green Chemical

17 Jiangsu Tianrong Group

18 Jiangsu Yangnong Chemical

19 Lianhe Chemical Technology

20 Lier Chemical

21 Limin Chemical

22 Nanjing Redsun

23 Nantong Jiangshan Agrochemical & Chemicals

24 Hailir Pesticides and Chemicals Group

25 Shandong Binnong Technology

26 Shandong Luba Chemical

27 Shandong Qiaochang Chemical

28 Shandong Weifang Rainbow Chemical

29 Shenyang Sciencreat Chemicals

30 Fuhua Tongda Agro-chemical Technology

31 Zhejiang Jinfanda Biochemical

32 Zhejiang Linghua Industry Company Limited

33 Zhejiang Qianjiang Biochemical

34 Zhejiang Wynca Chemical Industrial Group

35 Zhejiang Yongnong Chem. Ind.

36 Zhongshan Chemical Industries

For more information visit http://www.researchandmarkets.com/research/5vsz5z/company_profiles

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

RELATED LINKS
http://www.researchandmarkets.com

reade more...

TiO2 China Monthly Report 1401

DUBLIN, Feb. 20, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/p44zc3/tio2_china

) has announced the addition of the

"TiO2 China Monthly Report 1401"

report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

On Jan. 21, 2014, the National Bureau of Statistics of China (NBS) reported China's GDP (gross domestic product) in 2013, which was USD9.29 trillion, attaining a YoY growth rate of 7.7%. The 7.7% growth rate was higher than government's target, but obtained a 14 years' low. Meanwhile, due to government's control on real estate industry, the growth rate of domestic real estate industry in 2013 was 6.6%, which was 1.1% lower than the GDP growth.

In the beginning of 2014, the domestic TiO2 price declined further and the approaching of Spring Festival made the market more sluggish. Most domestic TiO2 producers took advantage of the Spring Festival to maintain their facilities. According to the authors' investigation, China produced 1.90 million tonnes of TiO2 in total in 2013, which was the same level as in 2012. However, the export volume of TiO2 in 2013 is expected to increase slightly while the domestic demand remained soft, and the TiO2 inventory at the end of 2013 was at a high level.

Key Topics Covered:

TiO2 import volume soared while export volume increased moderately in Nov.

Titanium feedstock imports increased while domestic output fell in Nov.

Domestic TiO2 market becomes quieter before the Spring Festival

Export growth to be the driving factor for China's TiO2 consumption in 2014

China produced around 1.90 million tonnes of TiO2 in 2013

It's wise for Shandong Dongjia to halt its IPO application

SRL attains massive growth in production but suffers massive drop in profit in 2013

Comparison of TiO2 properties indicators and requirements of end users

Increasing domestic auto output and lower raw material cost increase KNT's profit

Aroused public concern over pipeline safety to bring opportunities for anti-corrosion coating

Companies Mentioned:

Anada China Petroleum & Chemical Corporation CNNC Titanium DuPont GPRO Titanium Henan Billions Huntsman Pangang Group Rockwood Shandong Dongjia Shanghai Kinlita Chemical Co., Ltd. Sichuan Lomon Sierra Rutile Limited For more information visit http://www.researchandmarkets.com/research/p44zc3/tio2_china

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

RELATED LINKS
http://www.researchandmarkets.com

reade more...

ALCATEL ONETOUCH and IriTech demonstrate iris recognition for tablets at MWC 2014

FAIRFAX, Va., Feb. 21, 2014 /PRNewswire/ -- Mobile World Congress – ALCATEL ONETOUCH and IriTech (the global leader in iris recognition technology and a member of the Texas Instruments Design Network) will unveil a tablet device with integrated iris recognition during the MWC 2014.

The tablet demonstrates how iris recognition could be used to authenticate applications such as device lock/unlock, application launch control and data encryption. Taking seconds to scan and authenticate the user's iris, the technology holds the potential to bring ease-of-use and security benefits.

Dan Dery, Chief Marketing Officer for ALCATEL ONETOUCH said, "Ensuring a great user experience is at the heart of how we design software and hardware. We work closely with our partners to develop new approaches like iris scanning and are pleased to demonstrate a working example at Mobile World Congress."

Daniel Daehoon Kim, CEO for IriTech said, "There will be a myriad of applications derived from iris recognition enabled mobile devices. We are glad of this opportunity to prove its feasibility. Our goal for this prototype is to define a new era for iris recognition technology generally and a benchmark for IriTech's product particularly."

ALCATEL ONETOUCH and IriTech collaborated to install a small iris recognition camera module and IR LED, as well as IriTech's highly accurate matching algorithm, into a tablet device. The concept demonstrates the potential for integrating iris biometrics into mobile devices for security purposes and ease-of-use. Future applications include second factor authentication for mobile financial transaction, OTP (one-time-password) generation and remote vehicle control.

Visit ALCATEL ONETOUCH and IRITECH AT MWC Hall 6 Stand 6C30.

About ALCATEL ONETOUCH
ALCATEL ONETOUCH is simple, unexpected, down to earth, irreverent and colorful. We believe that what makes technology smart is what you can do with it rather than what it can do.

ALCATEL ONETOUCH is a brand within TCL Communication, an international multicultural company which designs, develops, and markets globally a growing range of mobile and Internet devices. TCL Communication is a public company listed on the Hong Kong Stock Exchange (2618.HK) and part of TCL Corporation one of the largest consumer electronics companies in the world.

ALCATEL ONETOUCH is a SMART MOVE.

For more information, please visit www.alcatelonetouch.com.

About IriTech, Inc.
IriTech is a global leader in Biometrics Technology with a passion for iris recognition technology. We have a singular focus on developing and introducing the best iris analysis and matching algorithms and the most compact yet powerful camera hardware.

Key milestones since inception in 2000:

Strong IP, holding over 60 patents including 3 key worldwide patents. Notably, IriTech is one of the only two vendors worldwide with internationally patented core iris matching algorithm #1 performance for accuracy and interoperability in the US government's NIST IREX 2008 test STQC certified cameras by the Indian Government for the Aadhaar project, the world's largest biometrics project at the moment Strategic partnership with Lockheed Martin & Texas Instruments Participated several other major government projects such as, US-VISIT program by the US Homeland security, US Navy & Military project etc.IRIS IS THE SOLUTION

For more information, please visit www.iritech.com.

Trademarks
All trademarks and registered trademarks belong to their respective owners.

About the Texas Instruments Design Network
IriTech, Inc. is a member of the TI Design Network, a premier group of independent, well-established companies that offer products and system-level design and manufacturing services complementing TI's semiconductors to a worldwide customer base to accelerate product innovation and time-to-market. Network members provide product design, hardware and software system integration, turnkey product design, RF and processor system modules, reference platforms, software development, proof-of-concept design, feasibility studies, research, certification compliance, prototyping, manufacturing, and product life cycle management. For more information about the TI Design Network, please visit http://www.ti.com/designnetwork.

SOURCE IriTech, Inc.

RELATED LINKS
http://www.iritech.com
http://www.alcatelonetouch.com

reade more...

Concise analysis of the international adhesives and sealants industry – forecasts to 2018

Dublin, 20 of February of 2014/PRNewswire /-

Research and markets

(

http://www.researchandmarkets.com/Research/6x3l5b/global_adhesives

) has announced the addition of the

"Concise analysis of the international adhesives and sealants industry – forecasts to 2018"

Report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The adhesives and sealants industry global is expected to witness a moderate growth and reach an estimated $58,14 billion for the 2018. Adhesives and sealants market is driven primarily by emerging economies, technological advances, globalization and increasing use of adhesives and sealants to seal and protect the materials in an environmentally friendly way. Packaging, automotive, construction and furniture industries are the main drivers of the adhesive and sealant industry. Sealants are determined mainly by automotive, electronics and construction.

Since the analysis presented, adhesives and sealants raw material suppliers as well as the producers recognize that there are valuable opportunities in the industry because of the stunning amount of demand and growth trends.

The study indicates that a growing number of end use applications has shown a marked change of technologies based on bra mechanics traditional based adhesive technologies, prominent among them being the transportation, electronics and medical sectors. Technological innovation is one of the main drivers of this industry. The strict regulations from the EPA (Environmental Protection Agency) and REACH (registration, evaluation, authorisation and restriction of chemicals) in the United States and Europe leading the industry of adhesives and sealants to a change of technology of adhesives with 100% solids adhesives solvent-based.

The report underlines that the main challenge of the industry is increasing fluctuations in the prices of raw materials for adhesives and sealants manufacture. Keeping pace with changing environmental standards is another challenge facing the industry. Manufacturers are under pressure to produce products with fewer volatile organic compounds (VOC), taking into account issues of health and safety.

The report provides key drivers and challenges that will help companies to identify their strengths, find if they are capable of facing the challenges and compete in the market. This study aims to provide the leaders of the sector with a competitive benchmarking of the world industry of adhesives and sealants. The study provides updated information on the market share, profit margins, capabilities and strategies of the leaders. The report helps current suppliers realistically evaluate their capacities, strategies, the visa-vis main competitors and provides executives competitor strategically important information, knowledge and data analysis.

This exclusive report will provide you with valuable information, knowledge and tools to identify new growth opportunities and run your business successfully in this market. This report will save hundreds of hours of his own personal research and will benefit significantly in expanding their business in this market. In the current strict economy, you have all the advantages that you can find.

Key topics:

1. Executive summary

2. global adhesives and sealants industry background and classifications

3. market analysis

4 financial (assets, debt, profitability and cost structure) analysis

5. competitive landscape and analysis of growth opportunities

6. industry strategic assessment

7. the company profiles of players

For more information visit http://www.researchandmarkets.com/research/6x3l5b/global_adhesives

Press contact: Laura Wood, + 353-1-481-1716, press@researchandmarkets.net

Markets and supply research

RELATED LINKS
http://www.researchandmarkets.com

reade more...

The market of FRP - forecasts to 2018 Global

Dublin, 20 of February of 2014/PRNewswire /-

Research and markets

(

http://www.researchandmarkets.com/Research/9q8xxh/the_global_frp

) has announced the addition of the

"The FRP Panel market - forecasts to 2018 World Cup"

Report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

After experiencing the decline in recent years, the global market of FRP plastic (FRP) Panel reported good growth in 2012. The future of the global industry of FRP Panel looks good with the opportunities of construction and transport industries. The total market is expected in 2018, which be 520 million pounds, valued at $496 million.

Much of the growth in this market can be attributed to three factors such as the increase of the requirements of energy efficiency for consumers, increasing the need for anticorrosive applications and greater attention in the total cost of the life cycle of finished products in comparison with those made of materials such as steel and aluminum. In terms of regional growth, APAC is expected to be the leader in growth followed by North America and Europe in 2013-2018.

Government regulation for VOC release and styrene emissions which adds to the costs of the manufacturers are challenging for the actors of the industry. The analysis indicates that in recent years, no new technology or new legislation was introduced that would significantly improve the growth of the global industry of FRP Panel. The FRP Panel products market; However, it will grow in digit during the next five years due to new opportunities, and insight into the growing market in certain applications.

For market expansion, the report suggests new product innovation where unique characteristics of composite materials can be capitalized. The report suggests to develop relationships with customers to create situation of win - win and develop low-cost solutions to the end user. A better part design (design composites-minded and not metal-minded), lowcost commodity raw material alternative, lower rate of waste and improved production efficiency would make parts composites more competitive cost. According to the study, new resin systems will be introduced in the FRP Panel of processing for a variety of reasons to increase line speed, to increase the flame, smoke and toxicity (FST) performance, to decrease the content of styrene and much more.

Key topics:

1. Executive summary

2 FRP Panel industry background and features

3. analysis of FRP panel global market 2012

4. competitive analysis

5. global FRP Panel market trends

6. global FRP Panel market forecasts

For more information visit

http://www.researchandmarkets.com/Research/9q8xxh/the_global_frp

Press contact: Laura Wood, + 353-1-481-1716, press@researchandmarkets.net

Markets and supply research

RELATED LINKS
http://www.researchandmarkets.com

reade more...

Concise analysis on the international corrosion inhibitors (organic and inorganic) market - forecasts to 2019

Dublin, 20 of February of 2014/PRNewswire /-

Research and markets

(

http://www.researchandmarkets.com/Research/3mwj3f/corrosion

) has announced the addition of the

"Concise analysis on the international corrosion inhibitors (organic and inorganic) market - forecasts to 2019"

Report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The water treatment market growth is expected to boost demand of corrosion inhibitors. In addition, the increasing use of corrosion inhibitors for several teams of steel and iron within the construction industry are expected to contribute to the growth of the market. However, several environmental problems related to the raw materials are expected to hamper the growth of the market. Advanced technology which has resulted in the increasing use of inhibitors of the Greens and the application of nanotechnology in corrosion inhibitors are expected to open up new opportunities for the growth of the market in the coming years.

Organic inhibitors represent the largest segment of product on the market of the corrosion inhibitors with more than 70% of the market in 2012. The absence of metals on the results of the corrosion inhibitors organic in the prevention of unwanted chemical reactions. The increasing use of organic inhibitors in the oil & gas and construction sector is expected to boost demand of this product segment. Organic inhibitors are expected to be the fastest growing segment within the period of prognosis due to the growing consumer preference. Inorganic inhibitors as molybdates are widely used in the treatment of the water.

Corrosion inhibitors base water dominated the market of corrosion inhibitors, representing more than 75% in 2012. Growing awareness about the harmful effects of volatile organic compounds () VOC emissions in human life coupled with low or negligible VOC emissions from water-based corrosion inhibitors are hopes that the momentum of demand for this application of the segment in the next few years. In addition, the growing demand of water based on inhibitors of corrosion in high temperature applications as the extraction of oil and refining is expected to be another factor contributing to the growth of the market. Oil / solvent are used in applications requiring a constant performance over the long duration of the time and the thickness of the continuous film that provides uniform protection corrosion inhibitors. They are used in applications such as automobiles and electronics.

Demand for corrosion inhibitors was greater in the power generation sector in 2012 representing more than 25% of the market in 2012. Oil & gas was the second largest final segment of corrosion inhibitors representing 19.4% of the market in 2012. Oil & gas is expected to the segment's fastest growing market due to the growing awareness of the losses due to corrosion. In addition, expected increase in industrial activities through various developed and developing countries to boost demand for oil & gas which in turn is intended to boost the market of corrosion inhibitors.

Key topics:

1 prologue

2. Executive summary

3 corrosion inhibitors: industry analysis

4 market of corrosion inhibitors: analysis of the product segment

5 market of corrosion inhibitors: analysis of the application

6 market of corrosion inhibitors: final analysis

7 market of corrosion inhibitors: Regional analysis

8 company profiles

Companies mentioned:

AkzoNobel Ashland BASF champion technologies Cortec Corporation Cytec Industries Dai-Ichi Karkaria Daubert Cromwell Dow Chemical Company Ecolab GE Water & process technologies Henkel AG & company Marott Graphic Services Solutia The Lubrizol Corporation W.RGrace & Co. For more information visit http://www.researchandmarkets.com/research/3mwj3f/corrosion

Press contact: Laura Wood, + 353-1-481-1716, press@researchandmarkets.net

Markets and supply research

RELATED LINKS
http://www.researchandmarkets.com/

reade more...

Molecular Cytogenetics Market - Forecast to 2019

DUBLIN, Feb. 19, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/jzx9mp/molecular

) has announced the addition of the

"Molecular Cytogenetics Market - Forecast to 2019"

report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Molecular cytogenetics refers to the study of chromosomal structures with the use of molecular techniques. The technique provides a combination of both molecular and cytological approach to research and diagnosis. Molecular cytogenetics is considered as an indispensable tool for the diagnosis and research of numerous chromosomal aberrations. The technique is preferred over traditional chromosomal banding technique as traditional techniques provide low resolution level and may escape detection of copy number variations.

The breakthrough in the molecular cytogenetics technologies such FISH and aCGH are providing new dimensions to the areas of research and molecular diagnostics. These techniques are considered as invaluable tool for gene mapping, gene discovery and complex disease trait analysis. Molecular cytogenetics facilitates diagnosis and prognosis of diseases associated with hematological malignancies and solid tumors at molecular level. Likewise, alongwith diagnosis and prognosis of tumors, the technique is facilitating the practice of personalized medicines. The global molecular cytogenetics market was valued at USD 469.2 million in 2012 and is expected to grow at a CAGR of 23.4% from 2013 to 2019 to reach at an estimated value of USD 1.9 billion in 2019.

Currently, aCGH technique is gaining momentum as compared to FISH technique owing to higher resolution over other traditional banding techniques. Earlier, where cytogenetics field was limited to identification of chromosome structure, it has now expanded its horizons to assessment of structural and functional genetic anomalies. FISH characterized by its ability to interpret information at genome level currently, captures the lion's share of the molecular cytogenetics market. The technique has been utilized over the past decade for identification of various diseases and in suggesting accurate treatment options to the physicians. The technique is known for its accuracy, speed, sensitivity and high resolution over the traditional methods. Further, owing to its growing importance in laboratories the technique is backed by technological advancements such as improved fluroscence microscopes and digital imaging. Moreover, the technique is also supported by ongoing developments in the field of genomics and bioinformatics. FISH has become an essential tool for the validation of diseases and is being extensively used in laboratories and hospitals.

Key Topics Covered:

1 Preface

2 Executive Summary

3 Market Overview

4 Molecular Cytogenetics Market, by Technology

5 Molecular Cytogenetics Market, by Applications

6 Molecular Cytogenetics Market, by Geography

7 Recommendations

8 Company Profiles

Companies Mentioned:

Abbott Laboratories Affymetrix, Inc Agilent Technologies, Inc Applied Spectral Imaging, Inc BI Biological Industries Bio-Rad Laboratories CytoTest Inc Cytognomix, Inc F Hoffmann-La Roche Ltd Illumina Inc LEICA BIOSYSTEMS Life Technologies Corporation Oxford Gene Technology PerkinElmer, Inc SciGene Corporation For more information visit http://www.researchandmarkets.com/research/jzx9mp/molecular

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

RELATED LINKS
http://www.researchandmarkets.com

reade more...

The World has Changed, Weakening the Security Once Afforded by Passwords, Finds Frost & Sullivan

MOUNTAIN VIEW, Calif., Feb. 19, 2014 /PRNewswire/ -- The strong authentication and one-time password (OTP) market is seeing steady growth due to several factors: the movement to cloud-based services; the demand for single, federated sign-on to software-as-a-service (SaaS) apps; the continuing growth of the threat landscape; open standard approaches; and innovative methods for stronger authentication. Biometrics is now the largest segment for strong authentication, with much of its momentum driven by the use of voice biometrics in call center and interactive voice response (IVR) applications.

Frost & Sullivan's new Analysis of the Strong Authentication and One-Time Password (OTP) Market finds the market earned revenue of $1.52 billion in 2013 and estimates this to reach $2.16 billion in 2018 at a compound annual growth rate of nearly 7 percent. The research notes new strong authentication methods are less expensive than the dominant hardware OTP method, fueling adoption. The analysis also finds RSA remains the largest vendor in the industry, with about one-fifth of the market revenue; however, the breadth of strong authentication methods creates a market for many players. This research covers hard token, USB key, biometrics, and soft token/device-as-a-token solutions.

For complimentary access to more information on this research, please visit: http://bit.ly/1eNZ8Ci

The explosive increase in users and the sheer number of distinct systems in work and personal lives is highlighting the importance of convenient authentication. Otherwise, the onslaught of system credentials may push users to revert to tactics that invalidate the intended security strength of passwords. As a result, security professionals are actively seeking ways to improve the strength of user authentication on their networks.

"Cloud-based services and bring your own device (BYOD) trends, in particular, demand speedy information exchange through the cloud for business continuity, and hence, security for these applications tops the priority list in most organizations," said Frank Dickson, Network Security industry principal at Frost & Sullivan. "As an extension of remote access to a network's sensitive data, strong authentication is beneficial in credential federation."

However, existing solutions are familiar and embedded in user's routines and so the introduction of new methods will require significant investment in user education. Overcoming strictly legacy hardware token authentication is another challenge.

Vendors must realize strong authentication security is a tool that customers use to manage risk. This means they must communicate the degree to which their solution mitigates risk when compared with competing solutions. Providing a compelling cost/benefit analysis will also aid chief information security officers win budget approval for improved authentication methods.

"The strong authentication market does not have a single future but many futures, as different use cases and levels of requirements will necessitate diverse solutions," opined Dickson. "To that end, attaining technology through acquisitions or licensing is a successful strategy to address product portfolio deficiencies."

Analysis of the Strong Authentication and One-Time Password (OTP) Market is part of the Network Security (http://www.networksecurity.frost.com) Growth Partnership Service program. Frost & Sullivan's related research services include: Analysis of the Global Vulnerability Management Market, Analysis of the Global Web and Email Content Security Market, Analysis of the SIEM and Log Management Market, and Analysis of the Global Mobile Endpoint Protection Market. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

Join Frost & Sullivan's interactive Visionary IT portal for the latest Information and Communication Technologies research, insights and tools to make winning, long-term business decisions. Visit: http://visionary-it.gilcommunity.com/

About Frost & Sullivan

Join Us: Join our community

Subscribe: Newsletter on "the next big thing"

Analysis of the Strong Authentication and One-Time Password (OTP) Market
ND12-74

Contact:
Britni Myers
Corporate Communications – North America
P: 210.477.8481
E: britni.myers@frost.com

Twitter: @FS_ITVision
LinkedIn: Future Growth Opportunities in ICT
Facebook: Frost & Sullivan

http://www.frost.com

SOURCE Frost & Sullivan

MedBox responds to critics and update on the status of issues to the shareholders of the company

WEST HOLLYWOOD, California, 18 February of 2014/PRNewswire /-Medbox, Inc. (OTC markets: MDBX) (www.medboxinc.com), a leader in consulting services services and systems patented medical industries and retail, issued a report to its shareholders in projects past, present and future. Company executives also comment on the bloggers seek to discredit the company to make money and law firms seeking to capitalize on misinformation in order to request from customers.

The following is a summary of the main events in the last few weeks:

MedBox filed its form 10 with the SEC in January and will be an SEC filer, with all the burdens and benefits resulting from that condition, from the middle of March 2014. MedBox issued a special stock dividend to shareholders and which was announced by FINRA on February 03, 2014. MedBox continues to accept customers licensing clinic in Nevada, Illinois, Colorado, Washington and Oregon. Executives of the company clarified its position on the restatement of financial statements that accompanied the registration statement form 10 filed with the SEC as a maturation process in becoming a Cabinet sec.

"The company undertook a project to bring the functions of accounting at home and during that long process we discovered some errors in accounting since then we have corrected the last financial statements included in the form 10. The point is to hit and be fully transparent with our stakeholders at all times,"said Vincent Mehdizadeh, Chairman at Medbox, Inc."the company has, as part of these corrections, instituted better controls over financial reporting to avoid major corrections. In addition, it is important to point out that revenues in the nine months of the year 2013 had increased during the comparative period of the year before (as corrected) and continue to add qualified people to accelerate our growth in the year 2014. Unfortunately, when you are the most visible company in the space, with a large market capitalization, you become a target."

Executives of the company caution the shareholders of the company while the media has been of great help Medbox as one of the only viable medical marijuana related to public companies, successfully there will always be opponents who publish deceptive and misleading articles about the company and its executives.

In addition, company executives said that the company offers support services to the sector of medical marijuana based on the length of an arm. Many times in a State where you are accepting applications for marijuana dispensary licenses, some owners are not leased to nonprofit entities recently formed made up of clients of the company. As a result, in some rare cases, and simply as an absolute benefit to its customers, it was agreed that Medbox lease properties and assign all rights to the applicant, with the permission of the owner.

"We are going the extra mile for our customers and that is evident through our glowing testimonials appear on our web sites," said Dr. Bruce Bedrick, CEO at Medbox, Inc. "it is interesting, with the recent banking policy guidance from the federal Government, now can begin to develop an additional source of income to acquire properties and lease clients of clinic operator." This is one of many sources of revenue that Medbox is developing actively given the current climate and the relaxed posture federal".

About Medbox, Inc.:

MedBox is a leader in the development, sales and service of systems of automated dosing and storage, biometrically controlled medicine and merchandise. MedBox has offices in New York, Arizona, Florida, and is headquartered in Los Angeles.

MedBox offers its patented systems, software and consulting services to pharmacies, clinics, urgent care centers, clinics of rehabilitation from drugs, hospitals, prison systems, hospice services and medical groups around the world. In addition, through its subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers a medical product industry award-winning vaporizer.

MedBox, Inc. is a company that is listed and traded in the OTC symbol MDBX markets.

Forward-looking statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. These statements are based on current beliefs and expectations and are inherently subject to important business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future strategies and decisions that are subject to change. We do not assume any obligation to update any forward-looking statements to reflect events or developments then made a statement with a vision for the future.

For more information about Medbox, please contact us at (800) 762-1452 or visit www.medboxinc.com.

Contacts:
Investor relations
Stephen Hart
Hayden IR
+ 1 - 917-658-7878
Hart@HaydenIR.com

SOURCE Medbox, Inc.

Call for abstracts: WMIC 2014 "Encouraging discoveries with Molecular Imaging"

CULVER CITY, Calif., 18 February 2014/PRNewswire /-on behalf of the Committee on scientific program of the World Congress of imaging Molecular (WMIC), are invited to submit an abstract for presentation or publication in 2014 WMIC, September 17-20 in Seoul, Korea.

"This year's theme, 'Discoveries driving with Molecular Imaging', underlines the global trend and to incorporate the molecular imaging in research and medicine to discover agents and new goals, visualize and learn about disease and to build a bridge for optimal results of the patient and cures,", said Marty Pagel Ph.d., Associate Professor of biomedical engineeringUniversity of Arizona and 2014 WMIC Program Chair.

Our program will focus on five emphasis: Chemistry & Imaging probes, first in human & clinical trials, preclinical studies of level to tissue & cell, in vivo preclinical studies and developments in Software technology &. Then these five will be divided into several categories offers a concentrated broad spectrum program.

World Molecular Imaging Congress proudly recognizes the exceptional commitment to research and the efforts of the next generation of researchers. To honor the distinction in its work, the WMIC will sponsor a contest prize to the young researcher. Finalist will be awarded $2,000 USD and you will be given the recognition that presents his talk during the closing ceremony. Two runners-up will receive $500 USD each.

World Molecular Imaging Congress is organized through the joint efforts of the world society of imaging Molecular (WMIS), European society for imaging Molecular (ESMI) and the Federation of Asian societies for imaging Molecular (FASMI). WMIC provides a unique platform for doctors, scientists and health care providers present the latest and most exciting discoveries that set global standards in molecular imaging.

The abstract submission deadline is Tuesday, April 01, 2014. Visit WMIS.ORG for information on submission guidelines.

IN WORLD MOLECULAR IMAGING SOCIETY
The WMIS is dedicated to developing and promoting translational research through multimodal molecular imaging. Education and the annual meeting of WMIC summaries is held in conjunction with the European society for imaging Molecular (ESMI) and Federation of Asian societies for imaging Molecular (FASMI). WMIC provides a unique platform for scientists and doctors with very diverse backgrounds interact, present and follow the cutting-edge advances in molecular imaging. Industry exhibits at the Congress includes the latest advances in preclinical and clinical imaging applications, creating a showcase for educational technology of molecular imaging to complete.

For more information: www.wmis.org

Contact: Christiaan Koop
Phone: 310-215-9730
email: CKOOP@wmis.org

SOURCE world Molecular Imaging Society

Medbox, Inc. Commends Obama Administration for New Guidelines Enabling Banks to Deal with Businesses that Legally Sell Marijuana

WEST HOLLYWOOD, Calif., Feb. 18, 2014 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing consulting services and patented medicine storage and dispensing systems to the medical and retail industries, today commended the Obama administration for issuing new rules intended to ease the concerns of banks wanting to deal with businesses that legally sell marijuana, and clearly outline limitations for federal prosecution of marijuana-related offenses.

Dr. Bruce Bedrick, chief executive officer of Medbox, will appear on CNBC's Closing Bell on Tuesday, February 18, and Fox Business on Wednesday, February 19 to discuss the new guidelines and what they could mean for the legal marijuana industry, including Medbox.

Dr. Bedrick is scheduled to appear as follows:

On Tuesday, February 18, Dr. Bedrick is scheduled to appear on CNBC's Closing Bell program at approximately 4:40 p.m. ET with hosts Bill Griffeth and Kelly Evans for a live, five-minute segment. On Wednesday, February 19, Dr. Bedrick is scheduled to appear FBN's After the Bell program during the 4 p.m. ET hour with hosts Liz Claman and David Asman for a live, five-minute segment.To date, 20 states and the District of Columbia have passed laws allowing the sale of medical and recreational marijuana, but its production, sale, and possession remain illegal under federal law. The miss-alignment of Federal and State laws has prevented the nation's banks from enabling dispensaries and other businesses in the legal marijuana industry to utilize the banking system, but today's rules should alleviate that problem.

The rules, issued by the Treasury and Justice Departments, will allow lawful marijuana businesses to have access to the American banking system when banks have verified that the businesses are properly licensed. Up until now, legal operators and vendors have had to conduct an all-cash business, making them potential targets for thieves. It is the responsibility of the banks to conduct due diligence about the types of products the vendors sell and the nature of the customers they serve. Accordingly, under the new rules, banks that believe a marijuana dealer is reputable will file a "marijuana limited" report.

In addition, The Justice Department issued a memorandum to prosecutors that closely follows guidance last August largely limiting federal enforcement priorities to eight types of crimes, including distribution to minors, cartel-related trafficking and distribution to states where marijuana is not legal. Businesses that do not violate federal law in these eight specific areas are cleared to access the American banking system, and per the DOJ memo, "may not" be prosecuted.

"Every financial institution will have to make its own risk assessment and whether it makes businesses sense," said an administration official. "While it may not reassure every bank, we're providing an opening for those who want to serve this sector." A Treasury Department official said demand has been especially heavy in Colorado and Washington, where retail sale of marijuana is now legal under state law.

As the industry leader in the legal marijuana industry, having consulted with more than 400 clients, helping businesses secure licenses, identify locations, build-out dispensaries, educate patients and conduct business in a safe, secure, and legally compliant way, Medbox strongly praises the comments from the federal administration.

"The market for legal marijuana is expected to exceed $3 billion this year," commented Dr. Bruce Bedrick, chief executive officer, Medbox, Inc. "We are encouraged by and commend the Obama administration for its forward-thinking action to ease the issues that banks currently have in doing business with dispensary operators which Medbox directly serves. This is yet another step in what we believe will be a steady progression to legalization of marijuana in most, if not all, states in the coming years."

About Medbox, Inc.:

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Headquartered in Los Angeles, Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical vaporizer product.

Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.

Forward-Looking Statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry, political conditions and economic conditions in the states considering such legislation. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

For more information on Medbox, please contact Medbox at (800) 762-1452 or go online to www.medboxinc.com.

Investor Relations:
Stephen Hart
Hayden IR
+1- 917-658-7878
hart@HaydenIR.com

SOURCE Medbox, Inc.

DERMALOG Wins 50 Million Dollar Contract for Nigerian Bank Project

Group photo at the opening ceremony of the DERMALOG biometric system for Nigeria's banks - including the Governor of the Central Bank, Sanusi Lamido Sanusi (centre), and the CEO of DERMALOG, Günther Mull (second from left).jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";HAMBURG, Germany, February 18, 2014 /PRNewswire/ --

The Nigerian financial system is becoming one of the most modern and safest in the world. DERMALOG Identification Systems is installing a nationwide system to identify all bank customers by fingerprint. The first phase is operational now.

(Photo: http://photos.prnewswire.com/prnh/20140218/671033-a )

(Photo: http://photos.prnewswire.com/prnh/20140218/671033-b )

On Valentine's Day, the pilot phase of the most comprehensive biometric project in Nigerian history was launched in Lagos. Sanusi Lamido Sanusi, Governor of the Central Bank of Nigeria, launched the biometric identification system for bank customers at a ceremony. This will in future enable the customers of all Nigerian banks to identify themselves at ATMs or at the checkout using their fingerprint so they can withdraw money or pay for goods. "Within the next year and a half, we will roll out the project in all banks nationwide," says Sanusi. "Thanks to the latest biometric technology, this will give Nigeria one of the most convenient and secure financial systems in the world."

50 million dollar project for Hamburg biometrics experts

The biometric system is supplied by company DERMALOG Identification Systems from Germany, which won an international tender by the Central Bank of Nigeria for the 50 million dollar project in autumn 2013. The DERMALOG system will now enable Nigerian banks to identify their customers correctly without the risk of forgery. It will therefore make a significant contribution in guarding against misuse in the financial sector and preventing money laundering and fraud by means of identity theft and fake identities. In addition, the use of fingerprints for identification will allow access to electronic monetary transactions for people with a low standard of education, as biometrics makes the use of banking easier.

"Fraud is one of the biggest challenges in the Nigerian banking sector," says Günther Mull, CEO of DERMALOG. "Thanks to secure and convenient fingerprint identification, in future it will no longer be possible to fake and misuse identities. This will solve one of the most pressing problems for the Central Bank of Nigeria. We are proud to support the bank in this endeavour." It will also make life easier for bank customers - in future they will not have to remember any PIN numbers or passwords and will simply place their finger on the reader. "Biometric technology therefore also greatly simplifies the lives of bank customers," says Mull.

Thanks to ongoing developments and innovations, DERMALOG's biometric technologies are now being used to provide greater security in over 110 major government installations in more than 60 countries. Thus, the Hamburg-based manufacturer is a world leader in the field of fingerprint biometrics and AFIS. The biometrics company provides both the software and the world's most secure fingerprint scanners thanks to cutting-edge liveness detection, and is now the market leader in this area of sensor development and production in Europe and many other parts of the world.

The wide product range of the biometrics manufacturer, combined with innovative technology and high-quality products, as well as the modular structure of its solutions, enables DERMALOG to adapt systems to meet individual customer requirements and to implement them successfully within a short period of time. DERMALOG is able to offer turnkey solutions and to integrate these, but often works jointly with local system integrators.

In addition to banks, DERMALOG technology is also in use in national border control systems and biometric identity cards and passports and of course as a biometric log-in method for computers. The aim is always to create a quick and simple process which at the same time provides more security.

DERMALOG Identification Systems GmbH, based in Hamburg, is the largest German biometrics manufacturer and is a world leader in biometric identification. A team of scientists and computer scientists works continually on new, innovative products. The company's product portfolio ranges from biometric border controls and biometric ID cards to new "finger login" and "finger payment" solutions. As well as Germany and Europe, Dermalog's main markets are Asia, Latin America and the Middle East.

In Germany, DERMALOG has supplied a total of over 20,000 fingerprint scanners for local registration offices and immigration authorities. These are being used to store fingerprints in new passports, ID cards and in residence permits. The company has now supplied a further 80,000 finger-scanners in more than 60 countries. Large AFIS installations (AFIS = Automatic Fingerprint Identification System) from Dermalog are now in use at over 110 government clients worldwide. Dermalog also provides systems for banks and ATM manufacturers, such as Wincor-Nixdorf, which has already equipped over 1000 ATMs worldwide with fingerprint technology from DERMALOG, allowing fingerprints to replace insecure PIN numbers. Further information is available at http://www.dermalog.com.

Press contact:
DERMALOG Identification Systems GmbH
Contact: Oliver von Treuenfels
Mittelweg 120
20148 Hamburg
Tel: +49(0)40-413227-0
Fax: +49(0)40-413227-89
Email: Oliver.vonTreuenfels@dermalog.com

SOURCE DERMALOG Identification Systems GmbH

reade more...

Credence ID lance un appareil mobile à triple biométrie innovant pour l'enrôlement et la vérification

- La conception totalement intégrée de Trident, basée sur Android™, produit une saisie rapide des données biométriques avec n'importe quel éclairage

EMERYVILLE, Californie, 14 février 2014 /PRNewswire/ -- Credence ID, LLC., une société de la baie de San Francisco, a annoncé aujourd'hui la disponibilité du Trident® le nouveau combiné à biométrie triple qui intègre une double saisie simultanée de l'iris, le capteur d'empreintes digitales FAP45, certifié PIV et un appareil photo. Ces trois fonctions sont totalement intégrées et activées par un hôte Android™ à quatre cœurs. Le produit est conçu pour répondre aux besoins des programmes biométriques à grande échelle, d'organisations civiles, militaires et policières et pour lesquels la mobilité et une saisie fiable dans toutes les conditions d'éclairage sont des exigences fondamentales. La souplesse d'Android permet également un développement rapide et simplifié des applications. Pesant moins de 1360 grammes, Trident donne aux opérateurs la capacité d'exécuter des concordances à la fois sur l'appareil ou par l'intermédiaire de multiples réseaux de communications, y compris cellulaire ou WIFI. Le GPS, pour la géolocalisation automatique et Bluetooth, pour la connexion des périphériques, sont également des fonctionnalités standard de Trident.

Les intégrateurs ou les développeurs de solutions peuvent désormais accélérer le développement des applications biométriques pour leurs clients en utilisant le système d'exploitation d'Android et le kit de développement logiciel de Credence, grâce auxquels les cycles de développement sont considérablement raccourcis et les appareils portables intelligents peuvent être équipés d'interfaces utilisateur graphiques dont l'aspect répond aux attentes des utilisateurs. Le kit de développement logiciel inclut également un code source pour de nombreuses fonctions communes, permettant aux partenaires de mettre les applications de leurs clients rapidement en service.

« Le marché de la biométrie avait besoin d'un appareil comme le Trident. Jusqu'à maintenant, la saisie de l'iris et des empreintes dans un appareil intégré était difficile lorsque la lumière naturelle était forte. Les appareils basés sur Windows, développés à l'origine pour les militaires, sont comparativement difficiles à utiliser en plein air et le développement d'applications pour nos clients était laborieux et onéreux. Les utilisateurs actuels peuvent compter sur un périphérique de poche aussi convivial que leur téléphone intelligent. C'est formidable de posséder tout cela dans un appareil source ouverte dont le coût est environ le tiers des autres équipements commercialisés actuellement », déclare Ken Nosker, PDG de Fulcrum Biometrics, distributeur autorisé et partenaire de Credence ID.

« Même si Credence est une entreprise relativement nouvelle, son équipe dirigeante et celle d'ingénierie ont de nombreuses années d'expérience dans le domaine de la biométrie. Trident représente la somme de toutes les leçons que nous avons apprises en matière de mobilité et de technologies de biométrie. Cet appareil associe idéalement la biométrie du visage, du doigt et de l'iris sur une plate-forme mobile d'avant-garde. Les activités telles que l'ID de l'électeur, la répartition des aides sociales, le passage de frontières, la banque mobile et la gestion des réfugiés sont quelques exemples de services qui bénéficieront de la présence d'un appareil abordable, mobile et convivial », déclare Bruce Hanson, PDG de Credence ID.

Pour plus de renseignements, y compris les caractéristiques détaillées, veuillez consulter www.credenceid.com.

A propos de Credence ID

Credence ID, LLC. est basée à dans la région de la baie de San Francisco. La société se spécialise dans l'innovation pour créer des produits de biométrie simples, élégants et équipés de multiples fonctionnalités. L'organisation possède une expertise commerciale et technique considérables dans des projets de technologies mobiles pour les empreintes digitales, l'iris et la reconnaissance faciale. Les cadres et les ingénieurs de Credence ID ont participé à nombreux programmes à grande échelle, nationaux et internationaux, d'enrôlement et d'identification, y compris ceux du DoD, AADHAAR (UID) des Etats-Unis, de l'AADHAAR (UID) en Inde, de l'Arabie Saoudite, de l'Indonésie, et du Pakistan. La société propose une gamme de produits qui fournissent des services complets d'enrôlement et d'identification, en tous lieux et à tout moment.

Pour plus de renseignements, veuillez composer le +1-888-243-5452, envoyez-nous un e-mail à sales@credenceid.com ou consultez www.credenceid.com

© 2014 Credence ID, LLC. Tous droits réservés. Credence ID et Trident sont des marques commerciales de Credence ID, LLC. déposées aux Etats-Unis et dans d'autres pays. Android est une marque commerciale de Google Inc. Toutes les autres marques commerciales ou marque déposées appartiennent à leurs propriétaires respectifs.

SOURCE Credence ID, LLC

Biosyntrx, Inc. Announces New Scientific Advisory Board Members

Steps to the Harvard Library Center of Knowledge. (PRNewsFoto/Biosyntrx, Inc.)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";COLORADO SPRINGS, Colo., Feb. 18, 2014 /PRNewswire/ -- Biosyntrx, Inc., a nutritional biotechnology and healthy lifestyles education company in the ophthalmic sector is proud to announce the addition of three new scientific advisory board members:

(Photo: http://photos.prnewswire.com/prnh/20140218/SF65884)

Lucy Young, MD, is Associate Professor of Ophthalmology at the Massachusetts Eye and Ear Infirmary, Harvard Medical School. She is the director of the Lancaster Course in Ophthalmology and has been on its faculty since 1990. Her publication list includes 95 peer review papers and book chapters. She is on the Best Doctors and U.S. News & World Report Top Doctors lists.

Richard Davis, MD, is a physician, inventor, and successful serial entrepreneur who has authored nearly 400 patents and trademarks worldwide, as well as sold four start-up companies to publicly traded companies. He is currently serving as the Chairman, President, and CEO of OgenX Therapeutics, a privately held mitochondrial medicines company focusing on solutions in Neurodegeneration, Oncology, and Virology in humans and animals.

Vincent de Luise, MD, is Assistant Clinical Professor of Ophthalmology at Yale University School of Medicine and Adjunct Clinical Assistant Professor of Ophthalmology at Weill Cornell Medical College. He serves on the editorial boards of the Cornea Journal and Eye World. As a post-doctoral fellow at Harvard University this past year, he developed a rubric for medical humanities education at both the undergraduate and medical school level.

About Biosyntrx, Inc.: Biosyntrx is a Colorado Springs, Colo.–based Nutritional Biotechnology Company with emphasis on ophthalmic nutrition science, professional crosstalk, and healthy lifestyles education. The primary Biosyntrx Eye Care Professional–recommended products are BioTears, a patented product that addresses the systemic nutrient needs of the dry eye patient, with millions of doses safely used by satisfied repeat customers, Macula Complete, a potent full-spectrum multiple designed for the those concerned about AMD, cataract, diabetic retinopathy, glaucoma, lack of energy, and optimal full-body health, also with millions of doses safely used by satisfied repeat customers. Oculair, a less potent full-body multiple, SightC+ for those who want or need daily or occasional megadoses of mineral-buffered vitamin C, Zeaxanthin-4 for those who want a 4 mg standalone zeaxanthin product, and EpiCor, a clinically proven immune system modulator. ?

For additional information, contact Biosyntrx CEO, Ellen Troyer, at etroyer@biosyntrx.com or office 719-227-7888 or cell 719-660-6676

SOURCE Biosyntrx, Inc.

Advanced Phase Change Materials - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2018

DUBLIN, Feb. 14, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/kd3msc/advanced_phase

) has announced the addition of the

"Advanced Phase Change Materials - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2018"

report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Advanced phase change materials (APCMs) are capable of storing and releasing high amounts of energy, whenever these materials change their state. Phase change materials can be segmented into organic, non-organic and bio-based. Increase in total energy supply, growth of construction industry in developed and developing economies and superior heat storage capacity of these materials are a few key drivers which are expected to increase the demand for APCMs. In addition, increasing use of these materials in the textile industry and temperature controlled packaging, coupled with the growth of these industries, is expected to boost the demand over the next few years. However, the high cost and hazardous nature of these materials is expected to hamper the growth of this market. Economic growth in emerging economies of Asia Pacific is expected to open new opportunities for the growth of this market.

Paraffin was the largest product segment of this market accounting for over 50% of the market in 2011. It has high heat storing capacity and is chemically stable in nature. However, other product segments of APCM which include bio-based phase change materials are expected to show the fastest growth within the forecast period. Growing demand for bio-based products is expected to be one of the primary factors expected to drive the demand for other phase change materials. In addition, research and development for this product segment is expected to boost its demand. Other product segment is expected to account for over 13% of the market in 2018.

APCMs in building and construction were the largest application segment within the market accounting for 24% of the market in 2011. Increasing population in large economies such as China, India and U.S. are driving the construction which in turn is expected to fuel the growth of APCM over the next few years. In addition, demand for green construction is expected to contribute to the growth of the market. Shipping and transportation is expected to be the second-fastest growing application segment of phase change materials. Increase trade activities and development of APCMs which enable transportation of perishable goods such as medicines and food is expected to drive the demand in this application segment. Shipping and transportation is expected to account for over 10% of the market in 2018.

Key Topics Covered:

1 Preface

2 Executive Summary

3 Advanced Phase Change Materials: Industry Analysis

4 Advanced Phase Change Materials Market: Product Segment Analysis

5 Advanced Phase Change Materials Market: Application Analysis

6 Advanced Phase Change Materials: Regional Analysis

7 Company Profiles

Companies Mentioned:

Advansa BV BASF Climator Sweden AB Cryopak Dow Building Solutions EI du Pont de Nemours & Company Honeywell International Phase Change Products Pty Ltd (PCP) Rubitherm Technologies GmbH Salca BV For more information visit http://www.researchandmarkets.com/research/kd3msc/advanced_phase

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

RELATED LINKS
http://www.researchandmarkets.com

reade more...

Concise Analysis of the International Molecular Diagnostics Markets

DUBLIN, Feb. 14, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/kkxpsb/molecular

) has announced the addition of the

"Concise Analysis of the International Molecular Diagnostics Markets"

report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The technologies that constitute molecular diagnostics - like first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors, and molecular labels - are influencing the discovery of therapeutic molecules, the screening and diagnosis of patients, and the optimization of drug therapy. In the past few years, this rapidly evolving field has seen several fascinating developments.

This report describes the specific market segment of the in vitro diagnostics market known as molecular diagnostics and includes all of the generally accepted clinical analytical activities in use today. It examines the prevalent clinical-measurement devices, as well as their reagents and supplies as utilized in hospitals, clinics, large reference laboratories and doctor's offices. Diagnostic tests marketed primarily as over-the-counter are generally not included in this report, although there is inevitably some overlap.

Main Objectives of Report

1) Identifying viable technology drivers through a comprehensive look at platform technologies for molecular diagnostics, including probe-based nucleic acid assays, microarrays and sequencing;

2) Obtaining a complete understanding of the chief molecular diagnostics tests--i.e., predictive, screening, prognostic, monitoring, pharmacogenomic and theranostic--from their basic principles to their applications;

3) Discovering feasible market opportunities by identifying high-growth applications in different clinical diagnostic areas and by focusing on expanding markets, such as communicable diseases, cardiology and oncology;

4) Focusing on global industry development through an in-depth analysis of the major world markets for molecular diagnostics, including growth forecasts.

Key Topics Covered:

1. Overview

2. Introduction to Molecular Diagnostics and PCR Technology

3. Business Landscape for the Molecular Diagnostics Market Sectors

4. Overview of Clinical Molecular Diagnostic Platforms on the Market

5. Molecular Diagnostic Testing and Infectious Diseases

6. Cancer Detection Using Molecular Diagnostics

7. Genetics Testing in Molecular Diagnostics

8. Molecular Diagnostics Uses in Industrial Testing and Food Diagnostics

9. Bioterrorism and Molecular Diagnostics

10. Regulatory Requirements

11. Reimbursement Issues and Billing Landscape for Molecular Diagnostics Testing

12. Company Profiles

Companies Mentioned:

Abbott Laboratories AdvanDx Agendia Agilent Technologies Ambry Genetics Arcxis Biotechnologies Atlas Genetics AutoGenomics, Inc Beckman Coulter Becton, Dickinson and Company Bio-Rad Laboratories Biodesix Biohelix Corporation Cancer Genetics, Inc Celera (acquired by Quest Diagnostics) Cepheid Clarient, Inc (GE Healthcare) CombiMatrix Corporation Cytocell Technologies Ltd DiagnoCure, Inc Enzo Biochem Epigenomics Exact Sciences Corporation Exagen Diagnostics, Inc Exiqon GenMark Diagnostics, Inc Genera Biosystems Genomic Health Great Basin Corporation Hologic Illumina IntegenX InterGenetics, Inc LabCorp Life Technologies Corporation Luminex Myriad Genetics, Inc Nanosphere Nanostring Natera Neogenomics NetBio Nuvera Biosciences Orion Genomics PerkinElmer Genetics Progenika QIAGEN NV Roche Diagnostics Rosetta Genomics Ltd Seegene Sequenom, Inc Siemens Healthcare Diagnostics (Siemens) Spartan Bioscience Thorne Diagnostics Transgenomic TrimGen Trovagene, Inc Veredus Laboratories Veridex bioMérieuxFor more information visit http://www.researchandmarkets.com/research/kkxpsb/molecular

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

RELATED LINKS
http://www.researchandmarkets.com

reade more...

In Vitro Diagnostics Market - Global Industry Analysis, Size, Share, Growth and Forecast to 2018

DUBLIN, Feb. 14, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/ztk89b/in_vitro

) has announced the addition of the

"In Vitro Diagnostics Market - Global Industry Analysis, Size, Share, Growth and Forecast to 2018"

report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of the body and therefore are essential in making well-informed medical decisions. This report estimates the market for the in vitro diagnostics terms of revenue (USD million) for the period 2012 - 2018, keeping 2011 as the base year.

The in vitro diagnostics market is segmented by geography and market by products. The market estimation for the U.S. and two emerging economies (China and India) have also been included in the report.

The U.S., India and China in vitro diagnostics market is segmented by products into clinical chemistry IVDs, Immunoassay IVDs, diabetes testing IVDs, blood testing IVDs, molecular diagnostics, and other IVDs. The global market for in vitro diagnostics is segmented on the basis of geography into North America, Europe, Asia-Pacific and rest of the world (RoW) regions and this market is provided in terms of USD million.

This report includes the market shares of key players in 2011. Moreover, company profiles for some of the key players are included in the report in terms of company overview, financial overview, business strategies, recent developments and product portfolio. The major companies included in the report are Abbott Laboratories Inc., Alere Inc., Bayer AG, Becton Dickinson and Company, Biomerieux SA, Beckman Coulter Inc., Danaher Corporation, Gen-Probe Incorporated, Johnson and Johnson, Life Technologies Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare (a division of Siemens AG) and Thermo Fisher Scientific Corporation.

Key Topics Covered:

1 Preface

2 Executive Summary

3 Market Overview

4 Global In Vitro Diagnostics Market, by Products (Qualitative information)

5 Global In Vitro Diagnostics Market, by Geography

6 U.S. In Vitro Diagnostics Market, by Products

7 China In Vitro Diagnostics Market, by Products

8 India In Vitro Diagnostics Market, by Products

9 Competitive Landscape

10 Company Profiles

Companies Mentioned:

Abbott Laboratories Inc Alere, Inc Bayer AG Beckman Coulter, Inc Becton, Dickinson and Company Biomerieux SA F Hoffmann-La Roche Ltd Gen-Probe Incorporated Johnson and Johnson Life Technologies Corporation Siemens Healthcare Thermo Fisher Scientific, Inc For more information visit http://www.researchandmarkets.com/research/ztk89b/in_vitro

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

RELATED LINKS
http://www.researchandmarkets.com

reade more...

Pages

.